CGS International Research

Broker's Calls

Special dividend from DBS, share buyback programme by UOB in CGSI’s forecasts ahead of FY2024 results

DBS will announce its results on Feb 11, followed by UOB on Feb 19 and OCBC on Feb 26.

Broker's Calls

CGSI resumes coverage of Food Empire with lower TP of $1.43

Analyst William Tng's valuation basis remains unchanged at 11.2 times FY2025 P/E or 1 standard deviation (s.d.) above its five-year mean from FY2019 to FY2023.
With 300MW wind-solar project win in India, Sembcorp at 64% of 2028 renewable energy goal: CGSI - THE EDGE SINGAPORE

Broker's Calls

With 300MW wind-solar project win in India, Sembcorp at 64% of 2028 renewable energy goal: CGSI

Sembcorp’s overall renewable energy gross capacity has reached 16GW, or 64% of its 2028 target of 25GW.
Analysts unchanged on ComfortDelGro target price after news of London taxi acquisition - THE EDGE SINGAPORE

Broker's Calls

Analysts maintain ComfortDelGro target price after news of London taxi acquisition

CDG intends to fund the purchase with external borrowings as it needs to pay off Addison Lee’s existing debt facilities in full upon completion.
Aztech Global is likely to maintain its eight-cent dividend over FY2024 to FY2026: CGSI - THE EDGE SINGAPORE

Broker's Calls

Aztech Global is likely to maintain its eight-cent dividend over FY2024 to FY2026: CGSI

Analyst William Tng kept his “add” call and TP of $1.21 after a visit to Aztech’s Pasir Gudang plant.

Broker's Calls

CGSI ups Hyphens Pharma’s TP on ‘healthy pipeline’ of products ahead

CGS International analyst Tay Wee Kuang believes this will support patmi growth.

Broker's Calls

‘Concerns overblown’ over Grab’s ‘muted’ 2QFY2024 results; analysts eye positive free cash flow promise

“Given the pullback in shares, we believe now is an attractive entry point with 47% upside,” says Morningstar.

Investing ideas

iFast’s ‘strong’ 2Q earnings beat wins praise

Target prices for iFast range from $8.03 to $10.50, against its current traded price of around $7.41.

Broker's Calls

Analysts mostly positive on Parkway Life REIT after DPU growth in 1HFY2024

CGSI, DBS and OCBC have kept their "buy" calls while Citi has kept its "neutral" call on the REIT.
CGSI ups iFast target price to 27% upside on 2QFY2024 earnings beat - THE EDGE SINGAPORE

Broker's Calls

CGSI ups iFast target price to 27% upside on 2QFY2024 earnings beat

iFast posted 2QFY2024 patmi of $16 million, up 11% q-o-q and 346% y-o-y.
×